P

Inventor

ZHAO YUFEN

US31 patents
⚠️ This page may combine multiple inventors who share the name “ZHAO YUFEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRISTOL MYERS SQUIBB CO

23 patents
US6916809B2Jul 12, 2005

Heterocyclic acridone inhibitors of IMPDH enzyme

BRISTOL MYERS SQUIBB CO61 citations94
US9273057B2Mar 1, 2016

Imidazotriazinecarbonitriles useful as kinase inhibitors

BRISTOL MYERS SQUIBB CO29 citations93
US7151176B2Dec 19, 2006

Pyrrolotriazine compounds

BRISTOL MYERS SQUIBB CO12 citations84
US9273014B2Mar 1, 2016

Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof

BRISTOL MYERS SQUIBB CO14 citations83
US8999918B2Apr 7, 2015

Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof

BRISTOL MYERS SQUIBB CO9 citations83
US7297695B2Nov 20, 2007

Pyrrolotriazine compounds as kinase inhibitors

BRISTOL MYERS SQUIBB CO9 citations74
US7141571B2Nov 28, 2006

Pyrrolotriazine compounds as kinase inhibitors

BRISTOL MYERS SQUIBB CO8 citations74
US11427610B2Aug 30, 2022

Cyclic dinucleotides as anticancer agents

BRISTOL MYERS SQUIBB CO2 citations73
US9492460B2Nov 15, 2016

Carbazole compounds useful as bromodomain inhibitors

BRISTOL MYERS SQUIBB CO4 citations73
US9708316B2Jul 18, 2017

TGFβR antagonists

BRISTOL MYERS SQUIBB CO5 citations72
US9556178B2Jan 31, 2017

Imidazotriazinecarbonitriles useful as kinase inhibitors

BRISTOL MYERS SQUIBB CO3 citations72
US11660311B2May 30, 2023

Cyclic dinucleotides as anticancer agents

BRISTOL MYERS SQUIBB CO2 citations71
US7846931B2Dec 7, 2010

Pyrrolotriazine compounds as kinase inhibitors

BRISTOL MYERS SQUIBB CO1 citations63
US7514435B2Apr 7, 2009

Pyrrolotriazine kinase inhibitors

BRISTOL MYERS SQUIBB CO3 citations63
US8940736B2Jan 27, 2015

Imidazotriazinecarbonitriles useful as kinase inhibitors

BRISTOL MYERS SQUIBB CO3 citations62
US11339185B2May 24, 2022

Cyclic dinucleotides as anticancer agents

BRISTOL MYERS SQUIBB CO0 citations60
US9427442B2Aug 30, 2016

Fluoroalkyl and fluorocycloalkyl 1,4-benzodiazepinone compounds

BRISTOL MYERS SQUIBB CO0 citations52
US7358256B2Apr 15, 2008

ATP competitive kinase inhibitors

BRISTOL MYERS SQUIBB CO0 citations52
US7312209B2Dec 25, 2007

Acridone inhibitors of IMPDH enzyme

BRISTOL MYERS SQUIBB CO0 citations51
US10519187B2Dec 31, 2019

Cyclic dinucleotides as anticancer agents

BRISTOL MYERS SQUIBB CO0 citations50
US9371328B2Jun 21, 2016

Imidazopyridazinecarbonitriles useful as kinase inhibitors

BRISTOL MYERS SQUIBB CO0 citations50
US9242941B2Jan 26, 2016

Alkyl, fluoroalkyl-1,4-benzodiazepinone compounds

BRISTOL MYERS SQUIBB CO0 citations41
US10744150B2Aug 18, 2020

Cyclic dinucleotides as anticancer agents

BRISTOL MYERS SQUIBB CO0 citations40

FINK BRIAN E

2 patents

INST PHARM & TOXICOLOGY AMMS

1 patent

BEIJING CHINA SCIENCE ORGANIC INNOVATION LLC

1 patent

ZHAO YUFEN

1 patent

GUANGDONG PHOBIOLOGY TECH CO LTD

1 patent

SHAN WEIFANG

1 patent

NORRIS DEREK J

1 patent